The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date. Very few paediatric cases have been published concerning the use of isavuconazole. | Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: The role of isavuconazole? A case report